NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Net Current Assets History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹674 Cr | ₹493 Cr | ₹322 Cr | ₹218 Cr | ₹181 Cr |
What is the latest Net Current Assets ratio of NEULAND LABORATORIES ?
Year | Net Current Assets |
---|---|
Mar2025 | ₹674 Cr |
Mar2024 | ₹493 Cr |
Mar2023 | ₹322 Cr |
Mar2022 | ₹218 Cr |
Mar2021 | ₹181 Cr |
How is Net Current Assets of NEULAND LABORATORIES Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2025 | ₹674 Cr | 36.57 | |
Mar2024 | ₹493 Cr | 53.26 | |
Mar2023 | ₹322 Cr | 47.92 | |
Mar2022 | ₹218 Cr | 20.19 | |
Mar2021 | ₹181 Cr | - |
Compare Net Current Assets of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹18,689.4 Cr | 25.1% | 10.7% | 55.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,069.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | 25.1% |
10.7% |
55.3% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses